Protective effects of oxymatrine on experimental diabetic nephropathy

Planta Medica

Volumn 80, Issue 4, 2014, Pages 269-276

  Guo, Changrun ^a   Han, Fengyu ^a   Zhang, Chunfeng ^a   Xiao, Wei ^a,b   Yang, Zhonglin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JIANGSU KANION PHARMACEUTICAL CO   (China)

Author keywords

diabetic nephropathy; Fabaceae; oxidative stress; oxymatrine; Sophora flavescens; TGF 1; TNF

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; CATALASE; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CYTOKINE; GLUCOSE; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; METFORMIN; OXYMATRINE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC NEPHROPATHY; DRUG EFFECT; GLOMERULUS; GLUCOSE BLOOD LEVEL; KIDNEY PARENCHYMA; KIDNEY TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANIMALIA; FABACEAE; RATTUS; SOPHORA FLAVESCENS;

ALBUMINURIA; ALKALOIDS; ANIMALS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEINURIA; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; SOPHORA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84896084584     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1360369     Document Type: Article

References (27)

1. Lopes A. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis: 2009; 19 S1 S47
2. Leese G., Savage M., Chattington P., Vora J. The diabetic patient with hypertension. Postgrad Med J: 1996; 72 263 268 (Pubitemid 26156197)
3. Mishra A., Bhatti R., Singh A., Ishar M. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med: 2010; 76 412 417
4. UKPDS United Kingdom Prospective Diabetic Study. Lancet: 1998; 352 837 853
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature: 2001; 414 813 820 (Pubitemid 34000785)
6. Tahara A., Tsukada J., Tomura Y., Yatsu T., Shibasaki M. Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells. Pharmacol Res: 2008; 57 142 150
7. Hu Y., Ye S., Zhao L., Zheng M., Chen Y. Hydrochloride pioglitazone decreases urinary TGF-beta1 excretion in type 2 diabetics. Eur J Clin Invest: 2010; 40 571 574
8. Wang Y., Zhao W., Xue R., Zhou Z., Liu F., Han Y., Ren G., Peng Z., Cen S., Chen H. Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Antivir Res: 2011; 89 227 231
9. Hong-Li S., Lei L., Lei S., Dan Z., De-Li D., Guo-Fen Q., Yan L., Wen-Feng C., Bao-Feng Y. Cardioprotective effects and underlying mechanisms of oxymatrine against ischemic myocardial injuries of rats. Phytother Res: 2008; 22 985 989
10. Gan R., Dong G., Yu J., Wang X., Yang S. Oxymatrine, the main alkaloid component of Sophora roots, protects heart against arrhythmias in rats. Planta Med: 2011; 77 226 230
11. Sugimoto H., Shikata K., Hirata K., Akiyama K., Matsuda M., Kushiro M., Shikata Y., Miyatake N., Miyasaka M., Makino H. Increased expression of intercellular adhesion molecule-1 in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes: 1997; 46 2075 2081 (Pubitemid 27512099)
12. Onozato M., Tojo A., Goto A., Fujita T., Wilcox S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int: 2002; 61 186 194 (Pubitemid 34075146)
13. Navarro J. F., Mora-Fernández C. The role of TNF- α in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev: 2006; 17 441 450 (Pubitemid 44803222)
14. Qi W., Chen X., Poronnik P., Pollock C. A. Transforming growth factor- β /connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol: 2008; 40 9 13 (Pubitemid 350064576)
15. Daroux M., Prévost G., Maillard L., Gaxatte C., Agati V., Schmidt A., Boulanger É. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab J: 2010; 36 1 10
16. Mao Y., Zeng M., Lu L., Wan M., Li C., Chen C., Fu Q., Wang J., She W., Cai X. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol: 2004; 10 3269 3273 (Pubitemid 39585463)
17. Wu D., Wen W., Qi C., Zhao R., Lü J., Zhong C., Chen Y. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. Phytomedicine: 2012; 19 712 718
18. Thomson S., McLennan S., Kirwan P., Heffernan S., Hennessy A., Yue D., Twigg S. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J Diabetes Complications: 2008; 22 284 294 (Pubitemid 351885491)
19. Mensah B., Obineche E., Galadari S., Chandranath E., Shahin A., Ahmed I., Patel S., Adem A. Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines. Cytokine: 2005; 31 180 190 (Pubitemid 40967901)
20. Hao H., Shao Z., Tang D., Lu Q., Chen X., Yin X., Wu J., Chen H. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sci: 2012; 91 959 967
21. Committee for the Update of the Guide for the Care and Use of Laboratory Animals Guide for the care and use of laboratory animals. Washington The National Academies Press: 2011
22. Wu D., Wen W., Qi C., Zhao R., Lü J., Zhong C., Chen Y. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. Phytomedicine: 2012; 19 712 718
23. Tahara A., Matsuyama Y., Shibasaki M. Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice. Eur J Pharmacol: 2011; 655 108 116
24. Veerapur V., Prabhakar K., Thippeswamy B., Bansal P., Srinivasan K., Unnikrishnan M. Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats: A mechanistic study. Food Chem: 2012; 132 186 193
25. Wang Y., Campbell T., Perry B., Beaurepaire C., Qin L. Hypoglycemic and insulin sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism: 2011; 60 298 305
26. Zhang S., Yang J., Li H., Li Y., Liu Y., Zhang D., Zhang F., Zhou W., Chen X. Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in Wistar rats. Eur J Pharmacol: 2012; 692 78 83
27. Honoré S., Cabrera W., Genta S., Sánchez S. Protective effect of yacon leaves decoction against early nephropathy in experimental diabetic rats. Food Chem Toxicol: 2012; 50 1704 1715